Proqr Therapeutics Nv

Penny Stocks Biotech Stocks Healthcare Stocks

$1.86

+0.01 (+0.54%)

As of Aug 15, 2:12 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +394.6% upside

Low Target $6.27

Average Target $9.20

High Target $10.38

Current Price $1.86

Current
$1.86

Target
$9.20

$6.27 $9.20 avg $10.38

Scenario Analysis

Bear Case

$6.27

237.1%

Low target

Base Case

$9.20

+394.6%

Avg target

Bull Case

$10.38

+458.1%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.10

-40.0% from high

52-Week Low

$1.33

+39.8% from low

Target vs 52W High

$9.20

+196.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%